Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Current Deferred Tax Assets (2016)

Utah Medical Products (UTMD) has 7 years of Current Deferred Tax Assets data on record, last reported at $393000.0 in Q4 2016.

  • For Q4 2016, Current Deferred Tax Assets rose 8.26% year-over-year to $393000.0; the TTM value through Dec 2016 reached $393000.0, up 8.26%, while the annual FY2016 figure was $393000.0, 8.26% up from the prior year.
  • Current Deferred Tax Assets reached $393000.0 in Q4 2016 per UTMD's latest filing, up from $363000.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $451000.0 in Q4 2012 and bottomed at $303000.0 in Q4 2014.
  • Average Current Deferred Tax Assets over 5 years is $367600.0, with a median of $363000.0 recorded in 2015.
  • Peak YoY movement for Current Deferred Tax Assets: surged 35.44% in 2012, then decreased 27.27% in 2013.
  • A 5-year view of Current Deferred Tax Assets shows it stood at $451000.0 in 2012, then fell by 27.27% to $328000.0 in 2013, then decreased by 7.62% to $303000.0 in 2014, then rose by 19.8% to $363000.0 in 2015, then rose by 8.26% to $393000.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Current Deferred Tax Assets were $393000.0 in Q4 2016, $363000.0 in Q4 2015, and $303000.0 in Q4 2014.